Diclofenac associated with cardiovascular health risk

A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...

Moving pharmacy forward

Australia’s healthcare system is strained but there is immense scope for the role of pharmacists to address the sector’s future burdens. At a time of...

Opinion: When a natural disaster hits

Dispensing from a house, a library and evacuation centres: that’s what happens in a flood. It’s almost 10 years since a flood put the majority...

Q&A: ‘I’m going overseas tomorrow . . . can you witness...

While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...

Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

Ready-to-use tool for oncology

Pharmacists have a new oncology-focused tool for the evaluation and assessment of adverse drug events in oncology. French researchers have developed a trigger tool to...